Responses
CASE REPORT
Chemotherapy-resistant breast implant-associated anaplastic large cell lymphoma
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 7 August 2018
- Published on: 7 August 2018Breast implant-associated ALCL is ALK negativeShow More
The case report by Parthasarathy et al. illustrates that breast implant-associated anaplastic large cell lymphoma (ALCL) can present as a locally aggressive tumor mass, and that this tumor can be refractory to chemotherapy and radiotherapy. In effect, the authors describe that the tumor was finally felt to be controlled after radical mastectomy including resection of the implant and its surrounding capsule.
The...
Conflict of Interest:
None declared.